4/15/2016 Table 1, Included drugs and their labeled indications ­ Drug Class Review: Newer Antihistamines ­ NCBI Bookshelf

Table 1 Included drugs and their labeled indications

Trade
Drug name(s) Labeled indications Dosage form/Route
Zyrtec® SAR; PAR; Chronic Urticaria Syrup/Oral
Cetirizine hydrochloride
Reactine®a SARb; PAR; Chronic Urticariac Tablet; Chewable tablet; Syrup/Oral
Loratadine Claritin® SAR; PARa; Chronic Urticaria Tablet; ODTa; Syrup; Capsuled/Oral
Fexofenadine Tablet; ODT; Suspension;
Allegra® SAR; PARa; Chronic Urticaria
hydrochloride Capsulea/Oral
Clarinex®d SAR; PAR; Chronic Urticaria Tablet; ODT; Syrup/Oral
Desloratadine Allergic Rhinitisc; SARb; Chronic
Aerius®a Tablet; Syrup/Oral
Urticaria
Levocetirizine Xyzal®d SAR; PAR; Chronic Urticaria Tablet; Solution/Oral
Astelin®d SAR Spray; Metered/Nasal
Azelastine
Astepro®d SAR; PAR Spray; Metered/Nasal
Olopatadine Patanase®d SAR Spray; Metered/Nasal

Abbreviations: ODT, orally disintegrating tablet; PAR, perennial allergic rhinitis; SAR, seasonal allergic rhinitis.

a Only available in Canada.

b For children only.

c For adults only.

d Not available in Canada.

From: Introduction
Drug Class Review: Newer Antihistamines: Final Report Update 2 [Internet].
Carson S, Lee N, Thakurta S.
Portland (OR): Oregon Health & Science University; 2010 May.

Copyright © 2010 by Oregon Health & Science University, Portland, Oregon 97239. All rights reserved.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

http://www.ncbi.nlm.nih.gov/books/NBK50554/table/introduction.t1/?report=objectonly 1/1